David Arkowitz, EVP, Chief Financial Officer at AMAG PHARMACEUTICALS INC. (AMAG), sold 2,705 shares at $17.06 ($46K) on 2011-02-24, disclosed to the SEC on 2011-02-28.
Scheduled sale ($46k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.06 | 2,205 | $38K | 81.5% |
| 2 | $17.10 | 500 | $9K | 18.5% |
| Total | $17.07 avg | 2,705 | $46K | 100% |
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |